(Q42258464)

English

Dose-response relationships of perphenazine in the treatment of acute psychoses

scientific article published on January 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Dose-response relationships of perphenazine in the treatment of acute psychoses (English)

1 reference

Europe PubMed Central

19 October 2017

author name string

L B Hansen

1

1 reference

Europe PubMed Central

19 October 2017

N E Larsen

2

1 reference

Europe PubMed Central

19 October 2017

N Gulmann

3

1 reference

Europe PubMed Central

19 October 2017

publication date

1 January 1982

1 reference

Europe PubMed Central

19 October 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

19 October 2017

78

1 reference

Europe PubMed Central

19 October 2017

2

1 reference

Europe PubMed Central

19 October 2017

112-115

1 reference

Europe PubMed Central

19 October 2017

https://scigraph.springernature.com/pub.10.1007/bf00432245

0 references

Determination of perphenazine and itssulphoxide metabolite olite in human plasma after therapeutic doses by gas chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma Level Monitoring of Antipsychotic Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood levels of thioridazine and some of its metabolites in psychiatric patients. A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic Criteria for Use in Psychiatric Research

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of Thioxanthenes in Plasma at Therapeutic Concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunoassay for fluphenazine in human plasma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/6817364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00432245

1 reference

Europe PubMed Central

19 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42258464&oldid=1940353800"